Some studies in animal models showed that several neurotrophins may be implicated in the regulation of light-dependent suprachiasmatic pacemaker and in other functions implicated in long-term memory acquisition during sleep. However, no data are known about the role played by NGF in ultradian regulation in humans. The aim of this study was to investigate whether or not there is a natural diurnal fluctuation during daytime in healthy and schizophrenic subjects with a normallightldark cycle. In a sample of 33 subjects (10 male schizophrenics and 23 healthy subjects) an ELISA assay was used to study the ultradian NGF cycle in blood samples at 9.00, 13.00 and 20.00 hours. The study showed an ultradian rhythm of NGF in healthy subjects with a "V" trend: higher at 9:00 and 20:00 and lower at 13:00. We also show significant differences between male and female controls. No NGF ultradian rhythm among schizophrenic patients compared to healthy subjects was found. The results of this study lead to a rhythmic NGF regulation that appears altered in schizophrenics, where higher levels in the morning and lower levels in the evening were observed, compared to the controls, and support the hypothesis of a role played by NGF in schizophr-enia.
Some studies in animal models showed that several neurotrophins, including Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), Neurotrophin-3 (NT-3) and Neurotrophin 4/5 (NT -4/5), may be implicated in the lightdependent regulation of the suprachiasmatic pacemaker and in other functions implicated in long-term memory acquisition during sleep (1,2,3).
Nerve Growth Factor (NGF) is a wellcharacterized neurotrophic factor (4) . It is essential for the survival of certain peripheral and central neurons during normal development and it promotes the differentiation and survival ofcholinergic basal forebrain neurons under a variety of experimental conditions (5) . Moreover, environmental changes, aggressive behaviour and anxiety-like responses alter circulating basal NGF level (6) . The data reported in recent years indicate that NGF also plays a role in some pathogenetic mechanism of schizophrenia (7 -12,) and regulates some functions of the immune system (13) . However, data are lacking concerning the role played by NGF in the diurnal regulation in humans. The aim of this study is to investigate whether in conditions of natural day light there is a fluctuation in healthy and schizophrenic subjects with a normal light! dark cycle.
MATERIALS AND METHODS
We studied a sample of33 subjects: 10schizophrenic male patients (mean age=24,n years; SD=2,59) who were admitted to the IIIo Psychiatric Clinic of the University "La Sapienza" in Rome, after meeting the DSM-IV (14) criteria for schizophrenia, in temporary 15day-long psychopharmacological wash-out, compared to 23 voluntary healthy subjects, 9 females (mean age=25,89 years; SD=I,54) and 14 males (mean age=24,43 years; SD=2,74). The psychopathology of the patients was assessed using the Scale for the Assessment of Positive Symptoms (SAPS), the Scale for the Assessment of Negative Symptoms (SANS) (15) , the Positive and Negative Syndrome Scale (PANSS) (16) and all the samples were assessed using the State-Trate Anxiety Inventory (ST AI) (17) .
The ultradian NGF cycle was studied in blood samples at 9:00, 13:00 and 20:00 hours. Five ml of blood was collected from the peripheral arm vein and immediately centrifuged at 6.000 g for IS min at 4 DC and the plasma was stored at -20 DC until NGF assay. All samples were analyzed by a researcher who was blinded to the group assignment of the subjects. NGF plasma levels were assessed using ELISA. NGF levels were measured with a highly sensitive two-site immunoenzymatic assay which recognizes human and murine NGF and is capable of detecting amounts as low as 5 pg/ml. Briefly, 96-well polystyrene microtube immunoplates (Nunc) were coated with affinity purified polyclonal goat anti-NGF antibody diluted in 0.05 M carbonate buffer (pH 9.6). Parallel wells were coated with purified goat IgG (Zymed, San Francisco, CA) for evaluation of the non-specific signal. After overnight incubation at room temperature and 2 hours incubation with a blocking buffer (0.05 M carbonate buffer pH 9.5 + 1% BSA9) plates were wahed with Tris-HCl pH 7.4 50 mM, NaCl 200 mM, 0,5% gelatine, 0.1 % Triton X-100. After extensive washing of the plates, the samples and the NGF standard solutions were diluted with sample buffer 0.1 % Triton X-100 (100 mM Tris-HCl pH 7.2, 400 mM NaCl, 4 mM EDTA, 0.2 mM PMSF, 0.2 mM benzethonium chloride, 2 mM benzamidine, 40 U/ml aprotinin, 0.05% sodium azide, 2% BSA and 0.5% gelatine), distributed into the wells and left at room temperature overnight. The plates were then washed and incubated with 4 mU/well anti-I3-NGF-13 galactosidase (Boehringer Mannheim, Germany) for 2 hours at 37 DC and, after another washing, 100 p.l of substrate solution (4 mg of chlorophenol red, Boehringer Mannheim, Germany/ml substrate buffer: 100 mM HEPES, ISO mM NaCl, 2 mM MgCl 2, 0.1% sodium azide and 1% BSA) were added to each well. After an incubation of 2 hours at 37 DC the optical density was measured at 575 nm using an ELISA reader (Dynatech), and the values of standards and samples were corrected by substraction of the background value due to nonspecific binding. Data were represented as pg/ml and all assays were performed in triplicate (18) . Under these conditions, the recovery of NGF was between 85 and 95%. Data was represented as pg/ml.
The Student's test for paired data was applied to assess statistical difference in mean NGF value in the different group at different time. The Pearson's correlation was used to investigate statistical correlation between mean NGF value and age and the symptom scales scores. Significance was defined as p valueeor 0.05.
RESULTS
The results are reported in Tab. I. In healthy subjects the difference between NGF plasma levels at different hours was significant: between the hours 9:00 and 13:00 (p=.003), 13.00 and 20.00 (p=.003) and between 9.00 and 20.00 (p=.03). The NGF ultradian rhythm is found both in male and female subjects. The difference is significant between the group of females and males at h. 13:00 (p=.008) and at h. 20:00 (p=.025), with higher NGF plasma levels in the first group (Fig.  1) . The difference is significant between schizophrenic patients and male healthy subjects at h. 9:00 (p=.003) and at h. 20:00 (p=.007) (Fig.  2) . No relationship between mean NGF plasma level and psychopatological status was found.
DISCUSSION
This is the first study in humans to demonstrate that healthy subjects have higher NGF plasma levels at 9:00 hand 20:00 h and lower at 13:00 h under natural day light. This finding suggests the existence of a diurnal neurotrophin regulation similar to what is typically observed in other hormones and neuropeptides (19) . The ultradian rhythm for NGF suggests that this protein may be regulated by different substances which, in turn, control other molecular functions (20) . Indeed, psycho-neuro-immuno-endocrinologycal studies conducted on NGF during the last years showed that it does play a key role in the function of coping among the nervous, endocrine and immune systems (13) . The observation of elevated NGF levels in early morning and before night suggests a highest NGF synthesis during night similar to what is observed for other endocrine molecules, such as melatonin (21) . This finding leads to a correlation between these two bio-active molecules, even in the framework of increased pineal NGF level that has been found by other researchers (22) . Furthermore, this study revealed significant differences between the average neurotrophin level between the sexes in controls. The present results show that females have higher NGF plasma levels than males. These data are not in line with the results of another study (23) perhaps due to differences in technique of analysis.
The most plausible hypothesis of these findings is concerned with a possible physiological difference between male and female subjects, similar to what has been already observed for other blood parameters. This difference could be accounted for by a stronger need of neuronal protection, or even in a supply which would be available in particular conditions. The lack of significant relations between NGF values and subjects' emotional states assessed by the STAI doesn't seem to be due to stress conditions. In fact, it is known that circulating NGF levels in both humans and animals may change under physical and/or psychological stress (6) ; however, in our sample, the careful control of possible stressful conditions, also supported by the reported scale values, counteracted by the possibility that stress could have influenced the NGF levels.
Another significant finding of the study is that male schizophrenics do not display NGF ultradian differences, in contrast to what is observed in healthy male subjects. In particular, while we observed a "V"-Iike trend of average plasma levels among healthy subjects, such a trend was lacking among schizophrenic subjects. In schizophrenics there are relatively high NGF levels in the morning, lower than the comparable levels in the control group, which tend to decrease steadily during the day. Our working hypothesis is that alterations in the bio-rhythms might affect NGF plasma levels in schizophrenics. Thus, it may be pointed out that functional or structural central impairments in different brain areas correlate with schizophrenia (cortex, hippocampal area, hypothalamus) involved in NGF synthesis, release or utilization may lead to diurnal NGF modifications (24) , also in the absence of psychopharmacological influence, since the schizophrenics were in the psychopharmacological wash-out phase for 15 days prior to the assessment (25, 26) . However, it is also true that previous studies demonstrated the presence of an altered NGF response following neuroleptic treatment, with a consequent reduction of plasma levels (7) . These very encouraging findings call for a further investigation on this topic with a methodology that makes it possble to record NGF plasma levels during the night. In particular, a record of the NGF nocturnal rhythm without day light would permit us to have additional information concerning the role that this molecule plays under physiological conditions. Finally, it would also permit us to compare the NGF profile with the ultradian profiles of other molecules involved in the etiopathogenesis of schizophrenia (27) (28) (29) (30) (31) (32) (33) .
